Researchers uncover dual role of B7-H3 in prostate tumor immune suppression

Researchers astatine The University of Texas MD Anderson Cancer Center person identified a antecedently chartless pathway that prostate tumors leverage to suppress the immune strategy by reshaping the tumor microenvironment to defy treatment. A combined targeted therapy attack improved antitumor responses and prolonged endurance successful preclinical models of castration-resistant prostate cancer.